Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  OrthoPediatrics Corp.    KIDS

ORTHOPEDIATRICS CORP.

(KIDS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/20/2021 01/21/2021 01/22/2021 01/25/2021 01/26/2021 Date
42.5(c) 42.61(c) 43.86(c) 45.64(c) 48.59 Last
166 709 160 444 119 615 514 716 266 000 Volume
-1.94% +0.26% +2.93% +4.06% +6.46% Change
More quotes
Financials (USD)
Sales 2020 72,5 M - -
Net income 2020 -24,0 M - -
Net Debt 2020 - - -
P/E ratio 2020 -34,1x
Yield 2020 -
Sales 2021 97,6 M - -
Net income 2021 -13,0 M - -
Net Debt 2021 - - -
P/E ratio 2021 -69,3x
Yield 2021 -
Capitalization 892 M 892 M -
Capi. / Sales 2020 12,3x
Capi. / Sales 2021 9,14x
Nbr of Employees 94
Free-Float 69,5%
More Financials
Company
OrthoPediatrics Corp. is a medical device company focused on providing product offerings to the pediatric orthopedic market for children with orthopedic conditions. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. The Company operates through the OrthoPediatrics segment, which designs, develops and markets... 
More about the company
Notations Surperformance© of OrthoPediatrics Corp.
Trading Rating : Investor Rating :
More Ratings
All news about ORTHOPEDIATRICS CORP.
01/22OrthoPediatrics Corp. Introduces Orthex in Australia
GL
01/19OrthoPediatrics Corp. Introduces Expanded Product Portfolio in Canada
GL
01/18ORTHOPEDIATRICS : ROSEN, RESPECTED INVESTOR COUNSEL Continues to Investigate Sec..
BU
01/15ORTHOPEDIATRICS : Expands Agent Network to Germany, Austria, Switzerland
MT
01/15ORTHOPEDIATRICS CORP : Regulation FD Disclosure, Financial Statements and Exhibi..
AQ
01/15OrthoPediatrics Corp. Expands its Agent Network in Three Strategic European C..
GL
01/14ORTHOPEDIATRICS : ROSEN, A TOP RANKED LAW FIRM, Continues to Investigate Securit..
PR
01/12ORTHOPEDIATRICS CORP : Regulation FD Disclosure, Financial Statements and Exhibi..
AQ
01/11ORTHOPEDIATRICS CORP : Results of Operations and Financial Condition, Financial ..
AQ
01/11ORTHOPEDIATRICS : Expects Higher Q4 Revenue
MT
01/11OrthoPediatrics Corp. Announces Preliminary Unaudited Revenue for Fourth Quar..
GL
01/11INVESTOR ALERT : Law Offices of Howard G. Smith Continues Investigation of Ortho..
BU
01/08GLANCY PRONGAY & MURRAY LLP : a National Class Action Law Firm, Continues Invest..
BU
01/08THE LAW OFFICES OF FRANK R. CRUZ : Continues its Investigation of OrthoPediatric..
BU
01/06ORTHOPEDIATRICS ALERT : Bragar Eagel & Squire, P.C. Is Investigating OrthoPediat..
BU
More news
News in other languages on ORTHOPEDIATRICS CORP.

- No features available -

More news
Chart ORTHOPEDIATRICS CORP.
Duration : Period :
OrthoPediatrics Corp. Technical Analysis Chart | KIDS | US68752L1008 | MarketScreener
Technical analysis trends ORTHOPEDIATRICS CORP.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 55,50 $
Last Close Price 45,64 $
Spread / Highest target 24,9%
Spread / Average Target 21,6%
Spread / Lowest Target 18,3%
EPS Revisions
Managers and Directors
NameTitle
Mark C. Throdahl Chief Executive Officer & Director
David R. Bailey President
Terry D Schlotterback Chairman
Fred L. Hite Director, Chief Operating & Financial Officer
Peter F. Armstrong Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ORTHOPEDIATRICS CORP.17.79%892
STRYKER CORPORATION-2.24%90 021
SMITH & NEPHEW PLC6.69%19 251
INSPIRE MEDICAL SYSTEMS, INC.14.27%5 789
VENUS MEDTECH (HANGZHOU) INC.20.24%5 186
GLAUKOS CORPORATION12.90%3 818